iBody Inc.

iBody Inc. is dedicated to contributing to advancements in diagnostics and therapeutics through its unique antibody generating technology. Located in Chikusa-ku, Nagoya-shi, Aichi, iBody Inc. specializes in the discovery of highly functional antibodies. Their proprietary technology facilitates the efficient and rapid discovery of useful antibodies from rabbits, alpacas, and even humans, producing antibodies with the properties necessary for diagnostics, reagents, and therapeutic agents.

iBody Inc. operates from its primary address at 2-22-8, Chikusa, Nagoya Life Science Incubator (NALIC) #417, Chikusa-ku, Nagoya-shi, Aichi 4640858, JP. The company is committed to discovering antibodies that are difficult to obtain with conventional technologies, thereby contributing significantly to human health and the development of cutting-edge medical solutions. iBody Inc. continues to expand its capabilities and impact in the biotechnology sector.

iBody Inc. is focused on leveraging its innovative antibody discovery platform to create impactful solutions for the healthcare industry. With a strong foundation in biotechnology research, iBody Inc. is poised for continued growth and success in the field. We invite the manager of iBody Inc. to create a customized and exclusive company showcase and product listing on our platform to further highlight their contributions.